CAP Submits Comments on Proposed 2027 Medicare Physician Fee Schedule
The College of American Pathologists (CAP) submitted comments to the proposed 2027 Medicare Physician Fee Schedule (PFS), addressing proposals that...
1 min read
brandon.rakes Jun 10, 2025
A bill introduced in the U.S. House of Representatives in late March seeks to increase transparency around prior authorization decisions.
The Reducing Medically Unnecessary Delays in Care Act of 2025 (H.R. 2433) would require Medicare coverage decisions, including prior authorization requirements and adverse coverage decisions, to be based on written clinical criteria developed in consultation with physicians. The bill mandates that all preauthorization decisions and adverse determinations must be made by a practicing physician in the same specialty as the health care provider who typically manages the medical condition or disease or provides the health care service. Stakeholder organizations, including the American Medical Association, are advocating in favor of the bill’s passage, which was referred to the House Energy & Commerce and Ways & Means committees for further consideration.
The bill outlines the following contract requirements for prior authorization medical decisions for Medicare administrative contractors (MACs) and Medicare Advantage (MA) plans:
Sources:
https://www.congress.gov/bill/119th-congress/house-bill/2433/text

The College of American Pathologists (CAP) submitted comments to the proposed 2027 Medicare Physician Fee Schedule (PFS), addressing proposals that...
The Centers for Medicare & Medicaid Services (CMS) plans to reduce preliminary Medicare payment rates for laboratory services.
United Healthcare announced Sept. 1 it is eliminating 30 percent of prior authorization requirements for certain plans.